Actress Christina Applegate, 54, is currently investigating the potential connection between her breast implants and her ongoing pain and fatigue, following her recent revelation of being misdiagnosed with multiple sclerosis (MS) in 2021.
During the November 10 episode of MeSsy, a podcast she co-hosts with Jamie-Lynn Sigler, Applegate, who rose to fame as a teenager on the popular sitcom Married With Children, mentioned that she had recently received a study indicating that symptoms linked to breast implants can mimic those of MS.
“Honestly, for the past five years or so, I kept thinking, ‘What if they’re leaking and making me sick?'” she expressed, adding that she intends to discuss this concern with her medical team.
-
As Christina Applegate reveals MS misdiagnosis, doctor warns of wrong treatment risks
-
The subject of Lyme disease is littered with misinformation. Celebrities are part of the problem, experts say
In 2008, Applegate underwent a double mastectomy and breast reconstruction after being diagnosed with an early stage of breast cancer and discovering she had a BRCA1 gene mutation, which increases the risk of breast and other cancers. On her podcast, she remarked that she was “long overdue” for a replacement of her implants.
She has also reported experiencing increasing pain and limited movement in her right shoulder, which can make it take her at least 10 minutes to sit up and get out of bed. These symptoms, she noted, are particularly challenging because “there are so many different factors that could be involved.”
Her inquiry follows doctors informing her in October that she does not have MS. At that time, Applegate mentioned that the news brought her back to “Square 1,” and her physical challenges persist as she is undergoing tests for other possible conditions, including rheumatoid arthritis, lupus, and Lyme disease.
While the origins of Applegate’s symptoms remain unidentified, there have been instances where breast implants have been associated with health issues, although the condition is not completely understood.
Understanding Breast Implant Illness

Breast implant illness, or BII, refers to symptoms experienced by some individuals with implants, such as fatigue, cognitive changes, joint discomfort, and muscle aches. This image depicts a Biocell textured breast implant by Allergan. (Nicolas Amaya/CBC)
Breast implant illness, commonly referred to as BII, encompasses a range of symptoms reported by individuals with implants.
As of December 31, 2025, Health Canada had documented 663 cases of symptoms or conditions associated with breast implants, amounting to approximately one report for every 1,025 implants sold in Canada.
Among the symptoms reported, fatigue was the most common, followed by mood alterations, gastrointestinal issues, and cognitive difficulties. It’s important to note that these are reports rather than confirmed diagnoses: Health Canada indicates that the available data cannot determine whether implants are the cause of these symptoms, which may stem from other sources.
The U.S. Food and Drug Administration (FDA) states that BII is not recognized as a formal medical diagnosis and lacks a specific test. Reports of symptoms such as fatigue and joint pain cannot clarify how frequently they occur or whether implants are responsible.
Julie Elliott, an advocate for breast implant illness and implant-related cancers in Canada, who has experienced health issues post-breast augmentation, informed CBC News that certain symptoms reported by individuals with implants may overlap with those of MS.
-
National breast implant registry much needed but long overdue, patients and doctors say
-
Alberta women with breast implant illness urge doctors to warn others of risk
“Chronic fatigue, memory issues, difficulties with concentration, numbness, tingling sensations, nerve pain, muscle weakness, and hair loss — these symptoms closely resemble those of MS,” Elliott noted.
However, she cautioned against establishing a direct link between Applegate’s implants and her symptoms. “I’m not implying that Christina Applegate’s breast implants are the cause of her issues,” she stated, emphasizing that it would be “premature and irresponsible” to make such assumptions.
“Similar symptoms do not automatically indicate the same diagnosis,” Elliott added. “Every possibility must be thoroughly examined without being dismissed or overlooked.”

Christina Applegate, left, arrives at the 29th Screen Actors Guild Awards in Century City, California, on February 26, 2023. (Valerie Macon/AFP/Getty Images)
Dr. Stephen Nicolaidis, a plastic surgeon from Montreal who has treated over 1,500 patients for implant removal, also highlighted the importance of exploring other potential causes.
He described BII as a “diagnosis of exclusion,” where patients must undergo thorough evaluations, and if no alternative cause is identified, consideration should be given to the possibility that the implants may be contributing to the issues.
Nicolaidis noted that common symptoms reported include fatigue, hair loss, skin rashes, breathing difficulties, joint and muscle pain, sleep disturbances, and brain fog, many of which can overlap with autoimmune disease symptoms.
Referring to the symptoms Applegate has publicly shared, he commented, “The symptoms she describes could indeed be linked to her breast implants.” However, the cause of BII is not well understood, and he stated that researchers have not yet uncovered definitive explanations for how implants may contribute to these symptoms.
There is no specific test for diagnosing BII, Nicolaidis explained. Imaging studies may reveal silicone outside an implant, but he noted that this finding is not necessary for a patient to report symptoms. He also emphasized that BII is distinct from implant-associated lymphoma, a cancer related to certain textured implants.
Concerns About Rupture, Removal, and Future Steps
A rupture or leak presents a separate issue from BII. The FDA identifies rupture and deflation as potential complications of implants and recommends that patients discuss any new or unusual breast changes with their healthcare provider.
Similarly, Health Canada advises individuals with implants to routinely check for any unusual breast changes and to communicate any signs or symptoms to their doctor. Decisions regarding whether to keep, replace, or remove implants should be made collaboratively with a clinician, taking into account individual symptoms, potential causes, and surgical risks.
They do not recommend preventive removal of implants due to associated surgical risks and advise those experiencing symptoms to consult with a healthcare provider.
-
Struggling with pain for years, N.S. woman heads to Montreal for breast implant removal
-
Video
The costly, complex and dangerous world of removing medical devices | The Implant Files
Nicolaidis encouraged individuals experiencing symptoms to seek comprehensive medical evaluations. If no other causes are identified, they can explore whether their implants may be a contributing factor and discuss options with their healthcare providers.
He stopped performing breast implant procedures in 2021, believing that the risks often outweighed the benefits, and now primarily focuses on implant removals. He noted that removal does not guarantee a complete resolution of issues. Nicolaidis mentioned that some patients with MS he has treated reported minimal improvement, and those with established autoimmune conditions may still require medical treatment following explant surgery.
Elliott believes it is essential that symptoms related to implants are taken seriously, even as their causes remain unclear. She urged patients to seek reliable, evidence-based information and monitor any changes in their health.
“The absence of conclusive answers does not mean that women’s experiences should be disregarded,” she stated.
